Episode 97: How to Make the Right Deal with a Large Biotech Company (and Avoid the Wrong One)
What does it really take to land a successful biotech partnership—and what makes a deal fall apart?
In this episode, host Elaine Hamm, PhD, sits down with Renee Williams, PhD, MBA, Founder and Managing Partner of Williams Biotech Consulting and Independent Board Director for AGS Therapeutics. With experience across major pharma companies like Eli Lilly and Janssen, Renee shares hard-earned insights from the front lines of dealmaking. From communication missteps to finding the right partner, she explains how to navigate biotech partnerships with clarity, confidence, and strategy.
In this episode, you’ll learn:
- Why overcommunication is key to every stage of the deal process.
- How to identify (and avoid) red flags in strategic partnerships.
- What scientists need to know to transition into biotech business roles.
Whether you’re negotiating a licensing deal or dreaming of your first exit, this episode is packed with advice you won’t want to miss.
Links:
Connect with Renee Williams, PhD, MBA, and check out Williams Biotech Consulting and AGS Therapeutics.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about Eli Lilly and Janssen Pharmaceutical.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
